While thrombospondin-1 (TSP-1) was mentioned for the first time two decades ago when elevated TSP-1 mRNA levels were found within ovarian tumors [29], most efforts focused on disrupting CD47/SIRPα up to now, in the purpose of promoting cancer cell phagocytosis. This evidence concerns the gene SIRPA and cancer.